Journal of Molecular Structure

Zabiulla and Al-Ostoot, Al-Ostoot, Fares Hezam and Khamees, Hussien Ahmed and Nagendra Prasad, M. N. and Zameer, Farhan (2022) Journal of Molecular Structure. Journal of Molecular Structure, 1270 (133963). ISSN 00222860

Text (Full Text) 1-s2.0-S0022286022016155-main-P2.pdf - Published Version Restricted to Registered users only Download (6MB) | Request a copy

Abstract

Xanthine oxidase (XO) is an interesting target for the synergic treatment of several diseases such as gout, hypertension, type 2 diabetes, and kidney disease. Associated complication includes hyperuricemia, which is considered one of the most common metabolic lifestyle disorders worldwide. Overproduction and in- sufficient excretion of uric acid during purine metabolism results in the formation of uric acid crystals in kidneys, joints, and other tissues. Allopurinol and Febuxostat, a clinically available drug used to reduce XO activity and serum uric acid level, are demonstrated to produce adverse effects including gastrointestinal distress, hypersensitivity, and skin rash, raising safety concerns. Exploring newer and novel XO inhibitors with minimum or no side effects is the aim of the current study. [1,3,4]-Thaidiazole analogs (7a-j) scaf- fold plays an important role in the design of efficient and potent inhibitors. In the present work, (7a-j) were evaluated for their ability to inhibit XO and found that among the series compound (7i) is selected as the best compound for inhibition of XO . Further, cyclooxygenases (COXs) and 5-lipoxygenase (5-LOX), enzymes that generate biologically active lipid molecules termed eicosanoids, are considered inflamma- tory and play a vital role in inflammatory pathways in the human body. Apart from their relation with inflammation, the additional involvement of COX-2 enzyme with cancer activity was recently discovered. In some cancer types, the level of COX-2 enzyme is increased indicating that this enzyme could be a suitable target for cancer therapy. Based on these findings, we have synthesized some new novel [1,3,4]- thiadiazole analogous (7a-j) and tested them against XO, COX, and LOX. To gain insight into the activity of XO, COX, and LOX inhibition, molecular docking studies were carried out for XO, COX, and LOX enzymes utilizing the newly synthesized compounds (7a-j) , and the results inferred that among the synthesized series of [1,3,4]-thiadiazoles (7a-j) , the compound (7i) showed extremely good result in both In silico and evaluation studies of XO, COX, and LOX, which is in agreement with the experimental results. Fur- thermore, density functional theory (DFT) was applied to calculate HOMO-LUMO, energy gap, and other parameters under the hybrid exchange-correlation functional (B3LYP) with the triple split valence basis set (6-311G).

Item Type:	Article
Uncontrolled Keywords:	Xanthine oxidase [1,3,4]-Thiadiazole In-silico DFT HOMO-LUMO COX LOX
Subjects:	C Chemical Science > Chemistry
Divisions:	Yuvaraj college > Chemistry
Depositing User:	Manjunatha Library Assistant
Date Deposited:	01 Dec 2025 06:22
Last Modified:	01 Dec 2025 06:22
URI:	http://eprints.uni-mysore.ac.in/id/eprint/18077

Actions (login required)

View Item